Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Assembly Biosciences (ASMB) Shares Issued (2017 - 2025)

Assembly Biosciences (ASMB) has 10 years of Shares Issued data on record, last reported at $5.5 million in Q3 2025.

  • For Q3 2025, Shares Issued changed N/A year-over-year to $5.5 million; the TTM value through Sep 2025 reached $7.5 million, up 265.86%, while the annual FY2024 figure was $2.0 million, N/A changed from the prior year.
  • Shares Issued reached $5.5 million in Q3 2025 per ASMB's latest filing, up from -$1.9 million in the prior quarter.
  • Across five years, Shares Issued topped out at $34.1 million in Q1 2021 and bottomed at -$4.5 million in Q4 2023.
  • Average Shares Issued over 5 years is $4.7 million, with a median of $2.6 million recorded in 2021.
  • Peak YoY movement for Shares Issued: soared 28586.55% in 2021, then crashed 1498.77% in 2023.
  • A 5-year view of Shares Issued shows it stood at $2.6 million in 2021, then tumbled by 87.5% to $325000.0 in 2022, then plummeted by 1498.77% to -$4.5 million in 2023, then surged by 144.65% to $2.0 million in 2024, then soared by 171.43% to $5.5 million in 2025.
  • Per Business Quant database, its latest 3 readings for Shares Issued were $5.5 million in Q3 2025, -$1.9 million in Q2 2025, and $1.9 million in Q1 2025.